Target intelligence / Profile preview

MicroRNA 9-1 (MIR9-1)

Target
MIR9-1
Molecular classification
MicroRNA (miRNA), Non-coding RNA
01

Overview

MicroRNA 9-1 (MIR9-1) is a non-coding RNA gene that produces miR-9, a highly conserved microRNA controlling gene expression at the post-transcriptional level by binding to target mRNAs and modulating their translation and stability[3]. MIR9-1, highly expressed in neural progenitor cells, governs neuronal differentiation, migration, and apoptosis by targeting multiple mRNA transcripts. It plays context-dependent roles in cancer, acting both as a tumor suppressor (e.g., in medulloblastoma via epigenetic silencing) and as an oncogene in other cancers. Aberrant MIR9-1 regulation is also associated with neurodegenerative diseases. Its molecular function and involvement in disease make MIR9-1 a candidate for diagnostic biomarkers and a potential, though challenging, therapeutic target[1][2][3].

Other names
hsa-mir-9-1MIRN9-1miRNA9-1mir-9-1
02

Mechanism of action

Mechanisms include modulation of miR-9-1 expression (re-expression, inhibition, or silencing) primarily via epigenetic regulation (e.g., CpG island hypermethylation reversal), miRNA mimics, and antisense inhibitors, which adjust post-transcriptional regulation of target mRNAs[2].

03

Biological functions

Post-transcriptional gene regulationNeural progenitor cell proliferationNeural migration and differentiationRegulation of apoptosisRegulation of cell cycleCell fate specification
04

Disease associations

Cancer (tumor suppressor and oncogenic roles, context dependent, e.g. medulloblastoma, breast cancer)Neurodegenerative disease (implicated in pathogenesis)Oral squamous cell carcinomaAutonomic nervous system neoplasm
05

Safety considerations

Off-target effects of miRNA-based therapeuticsPossible impact on cell differentiation and proliferation in critical tissues (e.g., CNS)Potential risk for unintended immune or apoptotic modulation
06

Biomarkers

Low expression or silencing of miR-9-1 as a potential marker for poor prognosis in medulloblastoma and possibly other cancers[2]Methylation status of the MIR9-1 locus may act as a diagnostic or predictive biomarker[2]

Beyond the preview

Go deeper on MicroRNA 9-1 (MIR9-1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MicroRNA 9-1 (MIR9-1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call